Patents by Inventor Ashish Jaiswal

Ashish Jaiswal has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230172943
    Abstract: Oral solid pharmaceutical compositions containing meloxicam co-crystals described herein allow for the use of meloxicam for the treatment of acute pain. In particular, the improved dissolution and bioavailability of the meloxicam co-crystal compositions provide more rapid uptake of meloxicam in vivo as evidenced by increase blood plasma concentrations in a decreased amount of time following administration. A correlation between improved plasma concentrations and in vivo analgesic action are provided for the first time.
    Type: Application
    Filed: April 20, 2021
    Publication date: June 8, 2023
    Applicant: Mylan Specialty L.P.
    Inventors: Richard Allan, Amit Antarkar, Santanu Chakraborty, Abhijit Deshmukh, Matthew A. Hummel, Ashish Jaiswal, Akhilesh Dixit, Ritesh Kakaria, Pankaj Patil, Russ Rackley, Andrew Shaw, Jeffrey P. Smith
  • Publication number: 20220351833
    Abstract: At least one example embodiment provides a computer-implemented method for evaluating at least one image data set of an imaging region of a patient, wherein at least one evaluation information describing at least one medical condition in an anatomical structure of the imaging region is determined.
    Type: Application
    Filed: April 27, 2022
    Publication date: November 3, 2022
    Applicant: Siemens Healthcare GmbH
    Inventors: Max SCHOEBINGER, Michael WELS, Chris SCHWEMMER, Mehmet Akif GULSUN, Serkan CIMEN, Felix LADES, Christian HOPFGARTNER, Suha AYMAN, Rumman KHAN, Ashish JAISWAL
  • Publication number: 20220184095
    Abstract: The solubility and bioavailability properties of meloxicam can be improved by preparing compositions of meloxicam co-crystals and reducing the particle size of (e.g., “nanosizing”) co-crystals. Such compositions with improved dissolution pharmacokinetic properties can be prepared by granulation and blending the co-crystals with extragranular excipients to provide oral solid dosage forms. As a result of the improved properties of the meloxicam oral dosage forms, the compositions may be useful for the treatment of pain, including acute pain.
    Type: Application
    Filed: April 21, 2020
    Publication date: June 16, 2022
    Inventors: Richard ALLAN, Amit ANTARKAR, Santanu CHAKRABORTY, Abhijit DESHMUKH, Akhilesh DIXIT, Matthew A. HUMMEL, Ashish JAISWAL, Ritesh KAKARIA, Pankaj PATIL, Russ RACKLEY, Andrew SHAW, Jeffrey P. SMITH
  • Publication number: 20120121722
    Abstract: The present invention relates to formulations comprising atazanavir and a silicate, and the process of preparation thereof, wherein the silicate is present in the extragranular portion.
    Type: Application
    Filed: December 17, 2009
    Publication date: May 17, 2012
    Inventors: Anup Avijit Choudhury, Ashish Jaiswal, Khalid Rafi, Rajeev Raghuvanshi
  • Publication number: 20070059360
    Abstract: Provided herein are water-dispersible pharmaceutical compositions comprising a combination of one or more anti-retroviral drugs useful for the treatment of Human Immunodeficiency Virus (HIV) infections. Also provided are processes for preparing such water-dispersible pharmaceutical compositions.
    Type: Application
    Filed: July 31, 2006
    Publication date: March 15, 2007
    Inventors: Ashish Jaiswal, Mukesh Garg, Ajay Singla
  • Publication number: 20050079228
    Abstract: The invention relates to clear, stable topical compositions of clarithromycin for the treatment of acne and processes for their preparation. The transparent topical compositions include clarithromycin, a zinc salt, a pharmaceutically acceptable vehicle and may include gelling agents.
    Type: Application
    Filed: May 28, 2004
    Publication date: April 14, 2005
    Inventors: Ashish Jaiswal, Mukesh Garg, Vinod Arora